Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Effect of Binder Type and Binder Level on the Properties of Agglomerates Containing Lactose and Dibasic Calcium Phosphate Dihydrate
The authors studied the effect of the combination of binders on the flow and compressibility characteristics of the agglomerates of binary combination of lactose and dibasic calcium phosphate dihydrate.


Pharmaceutical Technology
Volume 32, Issue 10, pp. 54-64

7. J.I. Wells, D.A. Bhatt, and K.A. Khan, "Improved Wet Massed Tableting using Plasticized Binder," J. Pharm. Pharmacol. 34 (suppl.), 46P (1982).

8. T. Abberger, "Influence of Binder Properties, Method of Addition, Powder Type and Operating Conditions on Fluid Melt Granulation and Resulting Tablet Properties," Pharmazie 56 (12), 949–952 (2001).

9. S.K. Joneja et al., "Investigating the Fundamental Effects of Binder on Pharmaceutical Tablet Performance," Drug Dev. Ind. Pharm. 25 (10), 129–135 (1999).

10. M.C. Gohel and P.D. Jogani, "Exploration of Melt Granulation Technique for the Development of Coprocessed Directly Compressible Adjuvant Containing Lactose and Microcrystalline Cellulose," Pharm. Dev. Technol. 8 (2), 143–151 (2003).

11. L. Rambali et al., "Using Experimental Design to Optimize the Process Parameters in Fluidized-Bed Granulation," Drug Dev. Ind. Pharm. 27 (1), 47–55 (2001).

12. S.I. Badway et al., "Effect of Process Parameters on Compressibility of Granulation Manufactured in a High-Shear Mixer," Int. J. Pharm. 198 (1), 51–61 (2000)

13. A. Cannon and K. Shemeley, "Statistical Evaluation of Vial Design Features that Influence Sublimation Rate during Primary Drying," Pharm. Res. 21 (3), 536–542 (2004).

14. W. Sibanda et al., "Experimental Design for the Formulation and Optimization of Novel Cross-Linked Oilispheres Developed for In Vitro Site-Specific Release of Mentha Piperita Oil," AAPS PharmSciTech. 5 (1), E18, 2004.

15. J.Z. Li et al., "The Role of Intra- and Extragranular Microcrystalline Cellulose in Tablet Dissolution," Pharm. Dev. Technol. 1 (4), 343–355 (1996).

16. A.Mckenna and D. F. McCafferty, "Effect of Particle Size on the Compaction Mechanism and Tensile Strength of Tablets," J. Pharm. Pharmacol. 34 (6), 347–351 (1982).

17. R.L. Carr, "Evaluating Flow Properties of Solids," Chem. Eng. 72, 163–168 (1965).

18. "Friability," in USP 24–NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), p. 2148.

19. "Disintegration Time," in USP 24–NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), p. 1941.

20. "Acetaminophen Tablets," in USP 24–NF 19 (United States Pharmacopoeial Convention, Rockville, MD, 2000), p. 20.

21. K.I. Chukwu and O.K. Udeala, "Binding Effectiveness of Colocassia esculenta Gum in Poorly Compressible Drugs: Acetaminophen and Metronidazole Tablet Formulation," Boll. Chim. Farm. 139 (2), 89–97 (2000).

22. S. Mattsson and C. Nystrom, "Evaluation of Critical Binder Properties Affecting the Compactibility of Binary Mixtures," Drug Dev. Ind. Pharm. 27 (3), 181–194 (2001).

23. R.L. Arellano, "Study of Load Capacity of Avicel PH-200 and Cellactose, Two Direct Compression Excipients Using Experimental Design," Drug Dev. Ind. Pharm. 26 (4), 465–469 (2000).

24. S.K. Nachaegari and A.K. Bansal, "Coprocessed Excipients for Solid Dosage Forms," Pharm. Technol. 28 (1), 32–42 (2004).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here